R Linse

Adjuvant low-dose interferon α2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis

Claus Garbe, Peter Radny, R Linse et al. · Annals of Oncology · 2008 · 138 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Temozolomide in Combination With Interferon-Alfa Versus Temozolomide Alone in Patients With Advanced Metastatic Melanoma: A Randomized, Phase III, Multicenter Study from the Dermatologic Cooperative Oncology Group

Roland Kaufmann, Konstanze Spieth, Ulrike Leiter et al. · Journal of Clinical Oncology · 2005 · 120 citations

Medicine, Oncology, Pharmacotherapy +12

Dacarbazine and interferon α with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG)

Axel Hauschild, Claus Garbe, W. Stolz et al. · British Journal of Cancer · 2001 · 91 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Efficacy of Low-Dose Interferon α2a 18 Versus 60 Months of Treatment in Patients With Primary Melanoma of ≥ 1.5 mm Tumor Thickness: Results of a Randomized Phase III DeCOG Trial

Axel Hauschild, Michael Weichenthal, Knuth Rass et al. · Journal of Clinical Oncology · 2010 · 79 citations

Medicine, Oncology, Pharmacotherapy +12

Intravenous dexamethasone‐cyclophosphamide pulse therapy in comparison with oral methylprednisolone‐azathioprine therapy in patients with pemphigus: Results of a multicenter prospectively randomized study

Ellen Cronan Rose, Sabine Wever, Detlef Zillikens et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2005 · 60 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +15